Japan Lifeline Co., Ltd., commonly referred to as Japan Lifeline, is a prominent player in the medical device industry, headquartered in Tokyo, Japan. Founded in 1994, the company has established itself as a leader in the distribution of innovative cardiovascular and electrophysiology products, serving healthcare professionals across Japan and other key regions. With a commitment to enhancing patient care, Japan Lifeline offers a range of unique products, including advanced catheter systems and diagnostic tools. The company is recognised for its strong partnerships with leading global manufacturers, ensuring access to cutting-edge technology. Japan Lifeline's dedication to quality and innovation has solidified its market position, making it a trusted name in the medical field.
How does Japan Lifeline's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Furniture Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Japan Lifeline's score of 25 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Japan Lifeline reported global carbon emissions of approximately 6,712,000 kg CO2e, comprising 1,454,000 kg CO2e from Scope 1 and 5,158,000 kg CO2e from Scope 2. For its operations in Japan, the company recorded emissions of about 4,783,000 kg CO2e, with 1,453,000 kg CO2e from Scope 1 and 3,208,000 kg CO2e from Scope 2. In 2022, the global emissions were about 6,720,000 kg CO2e, with Scope 1 contributing 1,436,000 kg CO2e and Scope 2 accounting for 5,284,000 kg CO2e. The company has not disclosed any specific reduction targets or initiatives, indicating a lack of formal commitments to reduce emissions at this time. Japan Lifeline's emissions data reflects its ongoing operations and highlights the importance of addressing carbon footprints within the medical device industry. The absence of detailed reduction strategies suggests potential areas for improvement in their sustainability efforts.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | 2023 | |
---|---|---|---|
Scope 1 | 1,488,000 | 0,000,000 | 0,000,000 |
Scope 2 | 5,462,000 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Japan Lifeline is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.